Richmond expansion continues

We now have 52 beds available for Phase 1 studies and a total of over 50 staff providing the necessary resource and expertise; at the present time over 200 volunteers are participating in a range of ongoing studies, both on an in and out-patient basis.Richmond Pharmacology has successfully implemented 14 studies since April 2002 including bridging studies with both Japanese and Caucasian volunteers. Two-thirds of these studies are for companies that feature in the top 10 global pharma companies.If you have requirements in Phase 1 clinical research with single or mixed origin volunteers, Richmond can provide the resource!